Jason Beaubien

The U.S. Food and Drug Administration's decision to temporarily halt the use of the Johnson & Johnson COVID-19 vaccine is having ramifications globally.

Soon after U.S. regulators paused the use of the J&J single-dose vaccine, health authorities in many European countries and in South Africa announced that they were also putting it on hold.

Rare, but potentially fatal blood clots linked to the AstraZeneca vaccine has lead to several countries limiting its use in young people. It's a vaccine many countries are depending on.

The European Medicines Agency says there is a possible link between the AstraZeneca COVID vaccine and rare blood clots.

The island nation is going it alone. No contracts with big drug makers, no support from WHO's vaccine program. If successful, Cuba will be the first producer of a vaccine in Latin America.

Some countries have made great strides in vaccinating their populations, but much of the world has made hardly any headway. Countries with excess vaccine stockpiles could loan doses to those in need.

A rare blood clotting condition has occurred in some people after receiving the AstraZeneca COVID-19 vaccine. If the new research is correct, it could mean that blood clots could be easily treated.

"Too many people are coming here right now," Mayor Dan Gelber said on Saturday as he proclaimed a 72-hour state of emergency to address swelling crowds and fears of fueling a surge in COVID-19 cases.

The agency's conclusion comes as the Biden administration announced it would send AstraZeneca vaccines to Canada and Mexico.

More European countries are suspending use of the AstraZeneca COVID-19 vaccine after reports that some recipients developed blood clots. The vaccine is not authorized in the United States.

The Prime Minister of Trinidad and Tobago gave an impassioned speech about the vaccine rollout, warning of hoarding and price gouging. Here's what we could find out about the cost of a dose.

For low- and middle-income countries, just obtaining doses has been a challenge. And now concerns are being raised about the effectiveness of the more affordable AstraZeneca option.

UNICEF says nearly 130 nations — home to more than a third for the world's population — have yet to administer a single dose of a coronavirus vaccine.

A small study in South Africa has raised concerns about the effectiveness of the AstraZeneca vaccine, particularly in fighting virus variants.

The World Health Organization is meeting to determine if it needs to change its guidance around the AstraZeneca COVID-19 vaccine due to questions of its efficacy against variants of the coronavirus.

As wealthier countries horde doses, the Latin American nation is struggling to obtain an ample supply for its population while dealing with a daunting caseload.

Swarms of locusts have reached dangerous levels in parts of Ethiopia, Somalia and Kenya. They're reproducing rapidly in part because of unusual rainfall patterns.

The team's owner said Jared Porter has been terminated after ESPN reported he repeatedly sent explicit messages to a reporter while he worked for the Chicago Cubs in 2016.

Some of the Honduran migrants in the caravan say they are hoping to see a change in U.S. asylum policy when President-elect Joe Biden takes office.

The nation has been hard hit by the pandemic. The president vowed to start a vaccination campaign by the end of 2020. That did happen — but not exactly as they'd hoped.